Cargando…

New developments in the management of COPD: clinical utility of indacaterol 75 μg

Chronic obstructive pulmonary disease (COPD) is a global health challenge and a major cause of mortality worldwide. Bronchodilators, particularly long-acting β(2)-agonists and long-acting antimuscarinic agents, used singly or in combination, aim to improve lung function, reduce symptoms, prevent exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steiropoulos, Paschalis, Archontogeorgis, Kostas, Nena, Evangelia, Bouros, Demosthenes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862584/ https://www.ncbi.nlm.nih.gov/pubmed/24353414 http://dx.doi.org/10.2147/COPD.S24940

Ejemplares similares

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?
por: Voulgaris, Athanasios, et al.
Publicado: (2023)

The role of vitamin D in obstructive sleep apnoea syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2018)

Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
por: Archontogeorgis, Konstantinos, et al.
Publicado: (2014)

Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea
por: Michailidis, Vassileios, et al.
Publicado: (2011)

Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2016)

HbA(1c) is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
por: Papanas, Nikolaos, et al.
Publicado: (2009)

Mean Platelet Volume and Platelet Distribution Width in Patients With Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease
por: Archontogeorgis, Kostas, et al.
Publicado: (2018)

Vitamin D Levels in Patients with Overlap Syndrome, Is It Associated with Disease Severity?
por: Archontogeorgis, Kostas, et al.
Publicado: (2022)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2012)

Predictors of obstructive sleep apnea in males with metabolic syndrome
por: Papanas, Nikolaos, et al.
Publicado: (2010)

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2018)

Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment
por: Archontogeorgis, Kostas, et al.
Publicado: (2015)

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2012)

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect
por: Siler, Thomas M, et al.
Publicado: (2014)

Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?
por: Steiropoulos, Paschalis, et al.
Publicado: (2010)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021)

Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data
por: Bleecker, Eugene R, et al.
Publicado: (2011)

Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2019)

Safety of indacaterol in the treatment of patients with COPD
por: Donohue, James F, et al.
Publicado: (2011)

Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study
por: Feldman, Gregory, et al.
Publicado: (2010)

COPD exacerbation: Lost in translation
por: Makris, Demosthenes, et al.
Publicado: (2009)

Is There Evidence of Early Vascular Disease in Patients with Obstructive Sleep Apnoea Without Known Comorbidities? Preliminary Findings
por: Steiropoulos, P, et al.
Publicado: (2013)

Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study
por: Salomon, Joerg, et al.
Publicado: (2017)

Biologic Therapies in Pediatric Asthma
por: Perikleous, Evanthia P., et al.
Publicado: (2022)

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
por: Beier, Jutta, et al.
Publicado: (2011)

Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions
por: Fouka, Evangelia, et al.
Publicado: (2022)

Sleep Quality and Mental Health of Medical Students in Greece During the COVID-19 Pandemic
por: Eleftheriou, Anna, et al.
Publicado: (2021)

The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2022)

Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome)
por: Voulgaris, Athanasios, et al.
Publicado: (2023)

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
por: Ridolo, Erminia, et al.
Publicado: (2019)

Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
por: Vincken, Walter, et al.
Publicado: (2014)

E-Cigarette Use Among Adolescents: An Overview of the Literature and Future Perspectives
por: Perikleous, Evanthia P., et al.
Publicado: (2018)

DNA Methylation in Pediatric Obstructive Sleep Apnea: An Overview of Preliminary Findings
por: Perikleous, Evanthia, et al.
Publicado: (2018)

Sleep Telemedicine Practices: Checkpoint List and Practical Considerations in the COVID-19 Era
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1at025nhv5b1m7k9p60mqdveru